Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.
Zabransky DJ; Smith HA; Thoburn CJ; Zahurak M; Keizman D; Carducci M; Eisenberger MA; McNeel DG; Drake CG; Antonarakis ES; The Prostate, 2012, vol. 72, issue 5, p 487, ISSN 10970045. ISBN 10970045.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef